Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Martin, AJM; Ortega, I; Font, C; Pachon, V; Castellon, V; Martinez-Marin, V; Salgado, M; Martinez, E; Calzas, J; Ruperez, A; Souto, JC; Martin, M; Salas, E; Soria, JM.

Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer

BRITISH JOURNAL OF CANCER. 2018; 118(8): 1056-1061 Nº de citas: 101 [doi:10.1038/s41416-018-0027-8]

Hanna, GJ; Busaidy, NL; Chau, NG; Wirth, LJ; Barletta, JA; Calles, A; Haddad, RI; Kraft, S; Cabanillas, ME; Rabinowits, G; O'Neill, A; Limaye, SA; Alexander, EK; Moore, FD; Misiwkeiwicz, K; Thomas, T; Nehs, M; Marqusee, E; Lee, SL; Janne, PA; Lorch, JH.

Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study

CLINICAL CANCER RESEARCH. 2018; 24(7): 1546-1553 Nº de citas: 100 [doi:10.1158/1078-0432.CCR-17-2297]

Di Leo, A; Jerusalem, G; Torres, R; Verhoeven, D; Pendergrass, K; Malorni, L; Lichfield, J; Martin, M.

First-line vs second-line fulvestrant for hormone receptor-positive advanced breast cancer: A post-hoc analysis of the CONFIRM study

BREAST. 2018; 38: 144-149 Nº de citas: 12 [doi:10.1016/j.breast.2017.12.016]

Garrido, P; Aldaz, A; Vera, R; Calleja, MA; de Alava, E; Martin, M; Matias-Guiu, X; Palacios, J.

Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH

CLINICAL & TRANSLATIONAL ONCOLOGY. 2018; 20(4): 443-447 Nº de citas: 16 [doi:10.1007/s12094-017-1740-0]

Grothey, A; Yoshino, T; Bodoky, G; Ciuleanu, T; Garcia-Carbonero, R; Garcia-Alfonso, P; Van Cutsem, E; Muro, K; Mytelka, DS; Li, L; Lipkovich, O; Hsu, Y; Sashegyi, A; Ferry, D; Nasroulah, F; Tabernero, J.

Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyses of the RAISE trial and validation in an electronic medical record data set

Esmo Open. 2018; 3(3): Nº de citas: 15 [doi:10.1136/esmoopen-2018-000347]

Turner, NC; Finn, RS; Martin, M; Im, SA; DeMichele, A; Ettl, J; Dieras, V; Moulder, S; Lipatov, O; Colleoni, M; Cristofanilli, M; Lu, DR; Mori, A; Giorgetti, C; Iyer, S; Bartlett, CH; Gelmon, KA.

Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastases

ANNALS OF ONCOLOGY. 2018; 29(3): 669-680 Nº de citas: 81 [doi:10.1093/annonc/mdx797]

Samaniego, R; Gutierrez-Gonzalez, A; Gutierrez-Seijo, A; Sanchez-Gregorio, S; Garcia-Gimenez, J; Mercader, E; Marquez-Rodas, I; Aviles, JA; Relloso, M; Sanchez-Mateos, P.

CCL20 Expression by Tumor-Associated Macrophages Predicts Progression of Human Primary Cutaneous Melanoma

Cancer Immunology Research. 2018; 6(3): 267-275 Nº de citas: 60 [doi:10.1158/2326-6066.CIR-17-0198]

Alsina, M; Rivera, F; Ramos, FJ; Galan, M; Lopez, R; Garcia-Alfonso, P; Ales-Martinez, JE; Queralt, B; Anton, A; Carrato, A; Gravalos, C; Mendez-Vidal, MJ; Lopez, C; de Mena, IR; Tabernero, J; Giralt, J; Aranda, E; GICOR.

A phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients

TARGETED ONCOLOGY. 2018; 13(1): 69-78 Nº de citas: 3 [doi:10.1007/s11523-017-0536-z]

Abad, A; Martinez-Balibrea, E; Vieitez, JM; Alonso-Orduna, V; Alfonso, PG; Manzano, JL; Massuti, B; Benavides, M; Carrato, A; Zanui, M; Gallego, J; Gravalos, C; Conde, V; Provencio, M; Valladares-Ayerbes, M; Salazar, R; Sastre, J; Montagut, C; Rivera, F; Aranda, E.

Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial

ANNALS OF ONCOLOGY. 2018; 29(2): 439-444 Nº de citas: 9 [doi:10.1093/annonc/mdx737]

Karachaliou, N; Gonzalez-Cao, M; Crespo, G; Drozdowskyj, A; Aldeguer, E; Gimenez-Capitan, A; Teixido, C; Molina-Vila, MA; Viteri, S; Gil, MD; Algarra, SM; Perez-Ruiz, E; Marquez-Rodas, I; Rodriguez-Abreu, D; Blanco, R; Puertolas, T; Royo, MA; Rosell, R.

Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients

Therapeutic Advances in Medical Oncology. 2018; 10: Nº de citas: 197 [doi:10.1177/1758834017749748]

Garcia-Gonzalez, X; Lopez-Tarruella, S; Garcia, MI; Gonzalez-Haba, E; Blanco, C; Salvador-Martin, S; Jerez, Y; Thomas, F; Jarama, M; Saez, MS; Martin, M; Lopez-Fernandez, LA.

Severe toxicity to capecitabine due to a new variant at a donor splicing site in the dihydropyrimidine dehydrogenase (DPYD) gene

Cancer Management and Research. 2018; 10: 4517-4522 Nº de citas: 4 [doi:10.2147/CMAR.S174470]

Castellano, D; Maroto, JP; Espinosa, E; Grande, E; Bolos, MV; Llinares, J; Esteban, E; del Alba, AG; Climent, MA; Arranz, JA; Mendez, MJ; Parra, EF; Anton-Aparicio, L; Bayona, C; Gallegos, I; Gallardo, E; Samaniego, L; Donas, JG.

Experience with Sunitinib in metastatic renal cell carcinoma (mRCC) patients: pooled analysis from 3 Spanish observational prospective studies

EXPERT OPINION ON DRUG SAFETY. 2018; 17(6): 573-579 Nº de citas: 2 [doi:10.1080/14740338.2017.1330410]

Martin, AM; Hidalgo, M; Alvarez, R; Arrazubi, V; Martinez-Galan, J; Salgado, M; Macarulla, T; Carrato, A.

From First Line to Sequential Treatment in the Management of Metastatic Pancreatic Cancer

Journal of Cancer. 2018; 9(11): 1978-1988 Nº de citas: 26 [doi:10.7150/jca.23716]

Carles, J; Mendez, MJ; Pinto, A; Saez, MI; Arranz, JA; Maroto, P; Lopez-Criado, P; Mellado, B; Donas, JG; Hernando, S; Leon, L; del Alba, AG; Lainez, N; Esteban, E; Reynes, G; Perez-Gracia, JL; Germa, JR; Lopez-Brea, M; Perez-Valderrama, B; Moretones, C; Castellano, D.

Radium-223 international early access program: results from the Spanish subset

Future Oncology. 2018; 14(1): 41-50 Nº de citas: 4 [doi:10.2217/fon-2017-0297]

Ruiz-Pinto, S; Pita, G; Martin, M; Alonso-Gordoa, T; Barnes, DR; Alonso, MR; Herraez, B; Garcia-Miguel, P; Alonso, J; Perez-Martinez, A; Carton, AJ; Gutierrez-Larraya, F; Garcia-Saenz, JA; Benitez, J; Easton, DF; Patino-Garcia, A; Gonzalez-Neira, A.

Exome array analysis identifies ETFB as a novel susceptibility gene for anthracycline-induced cardiotoxicity in cancer patients

BREAST CANCER RESEARCH AND TREATMENT. 2018; 167(1): 249-256 Nº de citas: 21 [doi:10.1007/s10549-017-4497-9]

Docampo, LCI; Arrula, VA; Rotllan, NB; Maseda, AC; Cirauqui, BC; Escobar, Y; Sorrosal, JJL; Borgonon, MP; Rueda, A; Hernandez, JJC.

SEOM clinical guidelines for the treatment of head and neck cancer (2017)

CLINICAL & TRANSLATIONAL ONCOLOGY. 2018; 20(1): 75-83 Nº de citas: 21 [doi:10.1007/s12094-017-1776-1]

Berrocal, A; Arance, A; Castellon, VE; de la Cruz, L; Espinosa, E; Cao, MG; Larriba, JLG; Marquez-Rodas, I; Soria, A; Algarra, SM.

SEOM clinical guideline for the management of malignant melanoma (2017)

CLINICAL & TRANSLATIONAL ONCOLOGY. 2018; 20(1): 69-74 Nº de citas: 12 [doi:10.1007/s12094-017-1768-1]

Cassinello, J; Arranz, JA; Piulats, JM; Sanchez, A; Perez-Valderrama, B; Mellado, B; Climent, MA; Olmos, D; Carles, J; Lazaro, M.

SEOM clinical guidelines for the treatment of metastatic prostate cancer (2017)

CLINICAL & TRANSLATIONAL ONCOLOGY. 2018; 20(1): 57-68 Nº de citas: 15 [doi:10.1007/s12094-017-1783-2]